Search

Your search keyword '"Bozzi, Elena"' showing total 168 results
Start Over Author "Bozzi, Elena"
168 results on '"Bozzi, Elena"'

2. The Paradox of Modern Technology in Standardizing Thermal Liver Ablation: Fostering Uniformity or Diversity?

Author

Verhagen, Coosje A. M., van der Velden, Ariadne L., Bale, Reto, Bozzi, Elena, Crocetti, Laura, Denys, Alban, van Erp, Gonnie C. M., Gholamiankhah, Faeze, Greco, Giorgio, Hendriks, Pim, Knapen, Robrecht R. M. M., Kobeiter, Hicham, Lanocita, Rodolfo, Meijerink, Martijn R., Orsi, Franco, Phillips, Alice, Rahmani, Hossein, Smits, Maarten L. J., van Strijen, Marco J. L., van Dam, Ronald M., van der Leij, Christiaan, and Burgmans, Mark C.

Published
2024
Full Text
View/download PDF

7. Safety and efficacy of Holmium-166 selective internal radiotherapy of primary and secondary liver cancer confirmed by real-world data

Author

Schulze-Zachau, Victor, primary, Verset, Gontran, additional, De Bondt, Pieter, additional, De Keukeleire, Katrien, additional, Gühne, Falk, additional, Heuschkel, Martin, additional, Hoffmann, Ralf-Thorsten, additional, Bozzi, Elena, additional, Sciuto, Rosa, additional, Lam, Marnix, additional, Deportós Moreno, Jordi, additional, Debrus, Roxane, additional, and Zech, Christoph J., additional

Published
2024
Full Text
View/download PDF

8. Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis

Author

Bargellini, Irene, Lorenzoni, Valentina, Lorenzoni, Giulia, Scalise, Paola, Andreozzi, Gianni, Bozzi, Elena, Giorgi, Luigi, Cervelli, Rosa, Scandiffio, Rossella, Perrone, Orsola, Meccia, Donato Vito, Boccuzzi, Antonio, Daviddi, Francesco, Cicorelli, Antonio, Lunardi, Alessandro, Crocetti, Laura, Turchetti, Giuseppe, and Cioni, Roberto

Published
2021
Full Text
View/download PDF

9. Safety and efficacy of Holmium-166 selective internal radiotherapy of primary and secondary liver cancer confirmed by real-world data

Author

Researchgr. Nucleaire Geneeskunde, Cancer, Schulze-Zachau, Victor, Verset, Gontran, De Bondt, Pieter, De Keukeleire, Katrien, Gühne, Falk, Heuschkel, Martin, Hoffmann, Ralf Thorsten, Bozzi, Elena, Sciuto, Rosa, Lam, Marnix, Deportós Moreno, Jordi, Debrus, Roxane, Zech, Christoph J., Researchgr. Nucleaire Geneeskunde, Cancer, Schulze-Zachau, Victor, Verset, Gontran, De Bondt, Pieter, De Keukeleire, Katrien, Gühne, Falk, Heuschkel, Martin, Hoffmann, Ralf Thorsten, Bozzi, Elena, Sciuto, Rosa, Lam, Marnix, Deportós Moreno, Jordi, Debrus, Roxane, and Zech, Christoph J.

Published
2024

10. Safety and efficacy of Holmium-166 selective internal radiotherapy of primary and secondary liver cancer confirmed by real-world data

Author

Schulze-Zachau, Victor, Verset, Gontran, De Bondt, Pieter, De Keukeleire, Katrien, Gühne, Falk, Heuschkel, Martin, Hoffmann, Ralf Thorsten, Bozzi, Elena, Sciuto, Rosa, Lam, Marnix M.G.E.H., Deportós Moreno, Jordi, Debrus, Roxane, Zech, Christoph Johannes C., Schulze-Zachau, Victor, Verset, Gontran, De Bondt, Pieter, De Keukeleire, Katrien, Gühne, Falk, Heuschkel, Martin, Hoffmann, Ralf Thorsten, Bozzi, Elena, Sciuto, Rosa, Lam, Marnix M.G.E.H., Deportós Moreno, Jordi, Debrus, Roxane, and Zech, Christoph Johannes C.

Abstract

Purpose: Holmium-166 has emerged as a promising option for selective internal radiotherapy (SIRT) for hepatic malignancies, but data on routine clinical use are lacking. The purpose of this study was to describe the safety and effectiveness of Holmium-166 SIRT in real-world practice through retrospective analysis of a multicenter registry. Methods: Retrospective analysis was conducted on Holmium-166 SIRT procedures performed between July 15, 2019, and July 15, 2021, across seven European centers. Treatment planning, treatment realization and post-treatment follow-up were conducted according to routine local practice. Safety and effectiveness data were extracted from the patients’ health records. Primary endpoint analysis was assessed for the entire study population with separate analysis for subgroups with hepatocellular carcinoma, metastatic colorectal cancer and intrahepatic cholangiocarcinoma. Results: A total of 167 SIRT procedures in 146 patients (mean age 66 ± 11 years, 68% male) were retrospectively evaluated. Most common tumor entities were hepatocellular carcinoma (n=55), metastatic colorectal cancer (n=35), intrahepatic cholangiocarcinoma (n=19) and metastatic neuroendocrine tumors (n=10). Nine adverse events grade ≥ 3 according to Common Terminology Criteria for Adverse Events were recorded, including one fatal case of radioembolization-induced liver disease. Response rates and median overall survival for the above mentioned subgroups were comparable to results from previous Holmium-166 trials as well as to results from Yttrium-90 registries. Conclusion: This study confirms that the safety and effectiveness of Holmium-166 SIRT derived from prospective trials also applies in routine clinical practice, reinforcing its potential as a viable treatment option for primary and secondary liver cancer., SCOPUS: ar.j, info:eu-repo/semantics/published

Published
2024

16. Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report

Author

De Vito,Andrea, Fiore,Vito, Urru,Valentina, Bozzi,Elena, Geremia,Nicholas, Princic,Elija, Canu,Donatella, Molicotti,Paola, Are,Riccardo, Babudieri,Sergio, and Madeddu,Giordano

Subjects
Hard to treat infection, Bedaquiline, MDR, Tuberculosis, Osteomyelitis, Bone infection
Abstract

Introduction Spinal Tuberculosis (STB) represents between 1% and 2% of total tuberculosis cases. STB management remains challenging; the first-line approach consists of medical treatment, while surgery is reserved for patients with complications. No data regarding STB treatment with bedaquiline-containing regimens are available in the literature. Case description Herein, we report the case of a 21-year-old man from Côte d'Ivoire with a multidrug resistance STB with subcutaneous abscess. After approval of the hospital off-label drug committee, we started bedaquiline 400 mg daily for two weeks, followed by 200 mg three times per week, for 22 weeks, associated with linezolid 600 mg daily, rifabutin 450 mg daily, and amikacin 750 mg daily (interrupted after eight weeks). During treatment, we performed a weekly EKG. No QT prolongation was shown, but inverted T waves appeared, requiring several cardiological consultations and cardiac MRI, but no cardiac dysfunction was found. After 24 weeks, bedaquiline was replaced with moxifloxacin 400 mg daily. The patient continued treatment for another year. We performed another computer tomography at the end of treatment, confirming the cure. Discussion A salvage regimen containing bedaquiline proved effective in treating multidrug-resistance tuberculosis spinal infection without causing severe adverse effects. However, further studies are needed to evaluate better bedaquiline bone penetration and the correct duration of treatment with bedaquiline in MDR spinal tuberculosis.

Published
2022

18. US Image Acquisition

Author

Bozzi, Elena, Crocetti, Laura, Lencioni, Riccardo, Baert, A. L., editor, Knauth, M., editor, Sartor, K., editor, Neri, Emanuele, editor, Caramella, Davide, editor, and Bartolozzi, Carlo, editor

Published
2008
Full Text
View/download PDF

19. Liver

Author

Crocetti, Laura, Bozzi, Elena, Della Pina, Clotilde, Lencioni, Riccardo, Bartolozzi, C., Baert, A. L., editor, Knauth, M., editor, Sartor, K., editor, Neri, Emanuele, editor, Caramella, Davide, editor, and Bartolozzi, Carlo, editor

Published
2008
Full Text
View/download PDF

21. Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report

Author

De Vito, Andrea, primary, Fiore, Vito, additional, Urru, Valentina, additional, Bozzi, Elena, additional, Geremia, Nicholas, additional, Princic, Elija, additional, Canu, Donatella, additional, Molicotti, Paola, additional, Are, Riccardo, additional, Babudieri, Sergio, additional, and Madeddu, Giordano, additional

Published
2022
Full Text
View/download PDF

26. Management of Liver Tumors during the COVID-19 Pandemic: The Added Value of Selective Internal Radiation Therapy (SIRT)

Author

Bargellini, Irene, primary, Boni, Giuseppe, additional, Traino, Antonio Claudio, additional, Bozzi, Elena, additional, Lorenzoni, Giulia, additional, Bianchi, Francesca, additional, Cervelli, Rosa, additional, Depalo, Tommaso, additional, Crocetti, Laura, additional, Volterrani, Duccio, additional, and Cioni, Roberto, additional

Published
2021
Full Text
View/download PDF

28. Treatment Response After Unusual Low Dose Sorafenib: Diagnosis with Perfusion CT and Follow-up in a Patient with Recurrent Hepatocellular Carcinoma

Author

Sacco, Rodolfo, Faggioni, Lorenzo, Bargellini, Irene, Romano, Antonio, Bertini, Marco, Ginanni, Barbara, Battaglia, Valentina, Bertoni, Michele, Bozzi, Elena, Federici, Graziana, Metrangolo, Salvatore, Parisi, Giuseppe, Neri, Emanuele, Sodini, Elisabetta, Tumino, Emanuele, Bresci, Giampaolo, and Bartolozzi, Carlo

Published
2012
Full Text
View/download PDF

37. Image-guided Cryotherapy for Musculoskeletal Tumors

Author

Scandiffio, Rossella, primary, Bozzi, Elena, additional, Ezeldin, Mohamed, additional, Capanna, Rodolfo, additional, Ceccoli, Matteo, additional, Colangeli, Simone, additional, Donati, Davide M., additional, and Colangeli, Marco, additional

Published
2021
Full Text
View/download PDF

38. Contributors

Author

Abujudeh, Hani, primary, Adam, Andreas, additional, Ahmad, Hassan M., additional, Ahn, Sun Ho, additional, Ahrar, Kamran, additional, Alaghmand, Morvarid, additional, Alfidja, Agaicha, additional, Alomari, Ahmad I., additional, Ambrosanio, Gennaro, additional, Ang, Soon Ghee, additional, Angle, John Frederick, additional, Ansel, Gary M., additional, Atassi, Bassel, additional, Auriol, Julien, additional, Baez, Juan Carlos, additional, Bakal, Curtis W., additional, Balzer, Jörn Oliver, additional, Barbato, Joel E., additional, Barnett, Brad P., additional, Baroud, Gamal, additional, Bartolozzi, Carlo, additional, Bauer, Jason R., additional, Baum, Richard Arthur, additional, Bell, Kevin Walter, additional, Bello, Jacqueline A., additional, Berkeley, Jennifer L., additional, Bettmann, Michael A., additional, Bezzi, Mario, additional, Bilbao, José I., additional, Bilecen, Deniz, additional, Binkert, Christoph A., additional, Bjarnason, Haraldur, additional, Black, James H., additional, Blei, Francine, additional, Block, Brian M., additional, Bohner, Marc, additional, Bolia, Amman, additional, Boos, Irene, additional, Botti, Charles F., additional, Boyer, Louis, additional, Bozzi, Elena, additional, Bream, Peter Reynolds, additional, Brem, Rachel F., additional, Brodie, Mark F., additional, Brook, Allan L., additional, Brooke, Benjamin S., additional, Brooks, Duncan Mark, additional, Brown, Daniel B., additional, Brown, Karen T., additional, Burnes, James P., additional, Burrows, Patricia E., additional, Campbell, Justin John, additional, Cantwell, Colin P., additional, Carreres, Thierry, additional, Carrino, John A., additional, Cassagnes, Lucie, additional, Chabrot, Pascal, additional, Chamsuddin, Abbas Afif, additional, Chang, Richard, additional, Chawla, Lakhmir S., additional, Chen, Hank (Han) K., additional, Chen, Yung-Hsin, additional, Chewning, Rush Hamilton, additional, Cho, Kenneth H., additional, Chun, Albert K., additional, Clark, Timothy W.I., additional, Collares, Felipe B., additional, Cova, Luca, additional, Crocetti, Laura, additional, Crum, Charles D., additional, Currier, T. Andrew, additional, Czeyda-Pommersheim, Ferenc, additional, Dake, Michael D., additional, Darcy, Michael David, additional, Dean, L. Mark, additional, De Baère, Thierry, additional, Desai, Sudhen B., additional, Diano, Alvaro A., additional, Dixon, Robert G., additional, Dominguez, Pablo D., additional, Dondelinger, Robert F., additional, Dubel, Gregory J., additional, Eskey, Clifford J., additional, Eubig, Jan A., additional, Faintuch, Salomão, additional, Fairman, Ronald N., additional, Fan, Chieh-Min, additional, Fanelli, Fabrizio, additional, Farber, Mark A., additional, Fayad, Laura M., additional, Ford, Peter F., additional, Funaki, Brian, additional, Gabelmann, Andreas, additional, Gagarin, Dmitri A., additional, Gailloud, Philippe, additional, Ganguli, Suvranu, additional, García-García, Lorenzo, additional, Gates, Vanessa L., additional, Geoghegan, Tony, additional, Gervais, Debra A., additional, Geschwind, Jean-Francois H., additional, Gillbert, Matthew B., additional, Given, Mark F., additional, Gobin, Y. Pierre, additional, Goldberg, S. Nahum, additional, Grawbow, Theodore S., additional, Greenberg, Roy K., additional, Grieme, Brian, additional, Hagspiel, Klaus D., additional, Hamilton, Keith W., additional, Hausegger, Klaus A., additional, Heim, Markus H., additional, Heng, Robert C., additional, Hirsch, Joshua A., additional, Todd Hobelmann, J., additional, Holden, Andrew H., additional, Horn, Ed, additional, Idowu, Oluwatoyin R., additional, Ierace, Tiziana, additional, Ignacio, Elizabeth Ann, additional, Irani, Zubin, additional, Izzo, Roberto, additional, Jackson, James E., additional, Jacob, Augustinus L., additional, Jaga, Priya, additional, Joffre, Francis, additional, Johnson, Matthew S., additional, Jones, Chauncey T., additional, Kalva, Sanjeeva P., additional, Kam, Anthony W., additional, Kamath, Sridhar, additional, Kandarpa, Krishna, additional, Katz, Jeffrey M., additional, Kaufman, John A., additional, Kelekis, Alexis D., additional, Keller, Frederick S., additional, Kerlan, Robert K., additional, Kessel, David, additional, Khan, Verena, additional, Khanna, Kanika, additional, Khilnani, Neil M., additional, Kim, Hyun S., additional, Kiyosue, Hiro, additional, Kos, Sebastian, additional, Kumar, Gaurav, additional, Kupershmidt, Maxim, additional, Kurli, Vineel, additional, LaBerge, Jeanne M., additional, Laffy, Pierre-Yves, additional, Lanciego, Carlos, additional, Lang, Elvira V., additional, Lavanga, Arcangelo L., additional, Lawler, Leo Patrick, additional, Lee, Judy M., additional, Lee, Michael J., additional, Lemettre, Thomas, additional, Lencioni, Riccardo, additional, Lim, Yean L., additional, Lewandowski, Robert J., additional, Lewin, John J., additional, Lewis, Curtis Allen, additional, Li, Changqing, additional, Liapi, Eleni, additional, Llinas, Rafael H., additional, Loose, Reinhard, additional, Lyon, Stuart M., additional, Malloy, Patrick C., additional, Manzano, Michael J., additional, Marachet, Marie Agnes, additional, Martin, Jean-Baptiste, additional, Martínez-Cuesta, Antonio, additional, Marx, M. Victoria, additional, Mathis, John M., additional, Matsumoto, Alan H., additional, Mauro, Matthew A., additional, McLennan, Gordon, additional, McPherson, Simon J., additional, McSwain, Hugh, additional, Meranze, Steven Greene, additional, Miller, Todd S., additional, Min, Robert J., additional, Mitchell, Sally E., additional, Moll, Stephan, additional, Mondschein, Jeffrey I., additional, Moore, Laurel E., additional, Morales, Jose Pablo, additional, Morgan, Robert A., additional, Mori, Hiromu, additional, Morrison, Paul R., additional, Müller-Hülsbeck, Stefan, additional, Murphy, Kieran P.J., additional, Murphy, Timothy P., additional, Muto, Mario, additional, Nanjundappa, Aravinda, additional, Narvaez, Juan C., additional, Do Nascimento, Rodrigo Gomes, additional, Nemcek, Albert A., additional, Noor, Ali, additional, Novelli, Luigi, additional, Orgera, Gianluigi, additional, Otal, Philippe, additional, Owen, Randall P., additional, Patel, Aalpen A., additional, Pauls, Sandra, additional, Pearl, Monica Smith, additional, Pelle, Giuseppe, additional, Pellerin, Olivier, additional, Picus, Daniel, additional, Pollak, Jeffrey S., additional, Portugaller, Rupert Horst, additional, Radzik, Batya R., additional, Rathbun, Suman W., additional, Ravel, Anne, additional, Ray, Charles E., additional, Razavi, Mahmood K., additional, Riina, Howard A., additional, Roberts, Anne, additional, Roche, Alain, additional, Roselli, Eric E., additional, Rosen, Robert J., additional, Rossi, Plinio, additional, Rousseau, Hervé, additional, Ruehm, Stefan G., additional, San Millán Ruíz, Diego, additional, Rundback, John H., additional, Saad, Wael E.A., additional, Sabharwal, Tarun, additional, Martinez Salazar, Gloria Maria, additional, Salerno, John Vito, additional, Salem, Riad, additional, Sapoval, Marc R., additional, Sarin, Shawn N., additional, Sharma, Sanjiv, additional, Shekoyan, Ashot, additional, Shin, Ji Hoon, additional, Silva, Naomi N., additional, Silverman, Stuart G., additional, Singh, Charan Kamal, additional, Sofocleous, Constantinos T., additional, Solbiati, Luigi, additional, Solomon, Stephen B., additional, Song, Ho-Young, additional, Soon, Kean H., additional, Sos, Thomas A., additional, Soulen, Michael C., additional, Spies, James B., additional, Stallmeyer, M.J. Bernadette, additional, Stavas, Joseph M., additional, Stokes, LeAnn Simmons, additional, Strecker, Ernst-Peter, additional, Streiff, Michael B., additional, Sudheendra, Deepak, additional, Tan, Walter A., additional, Tang, Elizabeth R., additional, Tehrani, Mahsa R., additional, Thompson, Mathew M., additional, Thompson, Kenneth R., additional, Tran, Gina D., additional, Trerotola, Scott O., additional, Trost, David, additional, Tulsyan, Nirman, additional, Tuncali, Kemal, additional, Turba, Ulku Cenk, additional, Uflacker, Renan, additional, Sonnenberg, Eric van, additional, Vasudevan, Prasanna, additional, Venbrux, Anthony C., additional, Vesely, Tom, additional, Vierasu, Bogdan, additional, Vile, Rachel L., additional, Vivas, Isabel, additional, Vorwerk, Dierk, additional, Waldman, David L., additional, Wallace, Michael J., additional, Watkinson, Anthony F., additional, Waybill, Peter N., additional, Weintraub, Joshua L., additional, White, Robert I., additional, Wholey, Mark H., additional, Winters, Bradford D., additional, Wityk, Robert, additional, Woo, Edward Y., additional, Wood, Bradford J., additional, Wyse, Gerald M., additional, Yoo, Albert J., additional, Yoon, Chang Jin, additional, Yung, Rex C., additional, Zaid, Soraya, additional, Zangan, Steven M., additional, Zawistowski, Grace M., additional, Zeccolini, Fabio, additional, Zeitler, Eberhard, additional, Zhang, Dianbo, additional, Zoarski, Gregg H., additional, and Zollikofer, Christoph L., additional

Published
2010
Full Text
View/download PDF

40. Predicting the coagulation volume induced by microwave ablation of hepatocellular carcinoma: the role of deposited energy, ex-vivo bovine liver charts and central hyperdense area on post-treatment CT

Author

Crocetti, Laura, primary, Amabile, Claudio, additional, Scalise, Paola, additional, Tosoratti, Nevio, additional, Bozzi, Elena, additional, Rossi, Piercarlo, additional, Cervelli, Rosa, additional, Cassarino, Simone, additional, and Cioni, Roberto, additional

Published
2021
Full Text
View/download PDF

44. Investigation of patients with new infection of echinococcal cyst in Sardinia, Italy.

Author

Santucciu, Cinzia, Bozzi, Elena, Profili, Stefano, Porcu, Alberto, Masala, Giovanna, Babudieri, Sergio, and Mastrandrea, Scilla

Subjects
*ARACHNOID cysts, *ECHINOCOCCUS granulosus, *CYSTS (Pathology), *THERAPEUTICS, *ZOONOSES, *INFECTION
Abstract

Cystic Echinococcosis (CE) is a zoonotic disease caused by the larval stage of a tapeworm of Taeniidae family, genus Echinococcus and species Echinococcus granulosus sensu lato (s.l.). CE is a worldwide public health problem and is highly incident in all Mediterranean areas. Following clinical, image techniques and serological investigations all 83 subjects involved in the study were diagnosed for CE. General and clinical data were entered into a database and evaluated. The 43.37% were female and 56.63% male, mean age was 50.71 while the range most represented (22.7%) was between 61->70 years. The purposes of our survey were to investigate these 83 patients enrolled in the study and to deeply examine 20 (24.10%) patients that developed a new echinococcal cyst. Moreover, the causes at the basis of the onset of a new cyst were analysed, together with a possible correlation with different treatments related to primary infection corresponding to surgery (n=7), albendazole (n=6), PAIR (n=3) and watch and wait (n=4). A possible link with medical treatments of the primary infection was observed in the subjects who underwent surgery or PAIR and a likely correlation attributable to high environmental contamination in subjects managed with drugs or watch and wait was detected. Moreover, our analysis evidenced that patients with a new infection presented a more severe diagnosis along with a major mortality rate. Finally, these data may have an important contribution for an epidemiological point of view concerning the percentage of CE in a specific geographical endemic area, such as Sardinia. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

45. Combined Treatments in Liver Ablations

Author

Bargellini, Irene, additional, Rossi, Piercarlo, additional, Crocetti, Laura, additional, Lorenzoni, Giulia, additional, Bozzi, Elena, additional, Lunardi, Alessandro, additional, and Cioni, Roberto, additional

Published
2019
Full Text
View/download PDF

46. Complete response for advanced liver cancer during sorafenib therapy: Case Report

Author

Romano Antonio, Battaglia Valentina, Altomare Emanuele, Bozzi Elena, Bertini Marco, Gianluigi Giannelli, Bargellini Irene, Sacco Rodolfo, Bertoni Michele, Capria Alfonso, Bresci Giampaolo, and Bartolozzi Carlo

Subjects
Diseases of the digestive system. Gastroenterology, RC799-869
Abstract

Abstract Background Hepatocellular carcinoma (HCC) is the fifth most common neoplasia in the world. In the past, treatment of advanced HCC with conventional antineoplastic drugs did not result in satisfactory outcomes: recently, in this patient population the oral multikinase inhibitor sorafenib has been able to induce a statistically significant improvement of overall survival. Similarly to other anti-angiogenic drugs employed in other tumour types, also sorafenib seldom induces the dimensional tumour shrinking usually observed with conventional cytotoxic drugs: data gathered from studies carried out with sorafenib and other competitors under development do not report any complete response in HCV-induced HCC. Case presentation An 84-year old man with a long-lasting history of chronic HCV hepatitis was referred to our Institution for an ultrasonography investigation of a focal hepatic lesion. To better characterize the liver disease and clearly define the diagnosis of the focal hepatic lesion, the patient was hospitalized in our department. Laboratory and instrumental investigations confirmed the clinical picture of HCV-related liver cirrhosis and identified a hepatic lesion of about 6 cm featuring infiltrating HCC with thrombosis of the portal trunk. Due to the advanced stage of the disease, therapy with sorafenib 400 mg bid was started. Right from one month after the treatment was started, a reduction of alpha-fetoprotein level was observed which, by the third month, turned down within the normal limits. In addition the CT scan showed 50% reduction of the neoplastic lesion along with canalization of the portal trunk. At the sixth month the normalization of the alpha-fetoprotein level at the lower limit of normality was confirmed and the MRI showed complete disappearance of the neoplasia. In addition a reduction of a metallo-proteinase serum level was obserdved. At the twelfth month a further MRI confirmed complete response had been maintained. At present the patient is in a follow-up program to evaluate the duration of the complete response. Conclusions This case is worth mentioning since, to the best of our knowledge, it represents the first evidence of complete response to sorafenib in an elderly patient with advanced HCV-related HCC.

Published
2011
Full Text
View/download PDF

48. Arterio-Venous Malformations (AVMs): imaging findings in a wide spectrum of localizations

Author

Bozzi, Elena

Subjects
Arteries / Aorta, Arteriovenous malformations, Vascular, Embolisation, Interventional vascular, MR, Ultrasound-Colour Doppler, CT-Angiography
Abstract

Learning objectives Background Imaging findings OR Procedure details Conclusion References Personal Information, Learning objectives: We proposed to attend this objectifs: Il l ustrate the different modalities of clinical presentation and the imaging findings in patients with Arterio-Venous Malformations (AVMs). Discuss and underline the added value of imaging in diagnosis and in...

Published
2013
Full Text
View/download PDF

49. Vascular arterial complications after orthotopic liver transplantation: incidence and treatment in a single-center experience

Author

Bozzi, Elena

Subjects
Arteries / Aorta, Cirrhosis, Liver, Angioplasty, Embolisation, Interventional vascular, Ultrasound-Colour Doppler, Grafts, Acute, Catheter arteriography, CT-Angiography, Thrombolysis
Abstract

Purpose Methods and Materials Results Conclusion References Personal Information, Purpose: Orthotopic liver transplantation (OLT) is the treatment of choice for acute/chronic hepatopathy or focal liver lesions, such as hepatocellular carcinoma (HCC). Post-OLT vascular arterial complications are the second most common cause of graft...

Published
2012
Full Text
View/download PDF

50. Treatment of hepatocellular carcinoma with conventional TACE and DEB-TACE: Comparison of the impact on liver function

Author

Bozzi, Elena

Subjects
Oncology, Interventional Radiology - Oncology, Interventional vascular, Interventional non-vascular
Abstract

Purpose Methods and Materials Results Conclusion References Personal Information, Purpose: To evaluate the impact on liver function of Transarterial Chemoembolization (TACE) in patients with liver cirrhosis and hepatocellular carcinoma (HCC) after conventional TACE (cTACE) and drug-eluting beads (DEB)...

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results